Molina Healthcare Signs CEO Joe Zubretsky to New Employment Agreement
Molina Healthcare (NYSE: MOH) has announced a contract amendment with President and CEO Joe Zubretsky, securing his leadership through at least the end of 2027. The Board of Directors has awarded Zubretsky, who joined Molina in November 2017, a special one-time stock grant that will vest at the end of 2027, contingent upon achieving certain financial targets. His annual compensation remains unchanged.
Chairman Dale Wolf expressed delight in Zubretsky's continued leadership, citing the company's right strategy, great execution, and significant value creation for shareholders under his tenure. This move demonstrates Molina's commitment to maintaining stable leadership and pursuing long-term financial goals.
Molina Healthcare (NYSE: MOH) ha annunciato una modifica al contratto con il Presidente e CEO Joe Zubretsky, garantendo la sua leadership fino almeno alla fine del 2027. Il Consiglio di Amministrazione ha conferito a Zubretsky, che è entrato a far parte di Molina nel novembre 2017, un grant azionario speciale una tantum che si concretizzerà alla fine del 2027, a condizione che vengano raggiunti determinati obiettivi finanziari. La sua retribuzione annuale rimane invariata.
Il Presidente Dale Wolf ha espresso soddisfazione per la continua leadership di Zubretsky, citando la strategia corretta, l'eccellente esecuzione e la significativa creazione di valore per gli azionisti durante il suo mandato. Questa mossa dimostra l'impegno di Molina a mantenere una leadership stabile e a perseguire obiettivi finanziari a lungo termine.
Molina Healthcare (NYSE: MOH) ha anunciado una enmienda al contrato con el presidente y CEO Joe Zubretsky, asegurando su liderazgo al menos hasta finales de 2027. La Junta Directiva ha otorgado a Zubretsky, que se unió a Molina en noviembre de 2017, una concesión especial de acciones única que se hará efectiva a finales de 2027, sujeta al cumplimiento de ciertos objetivos financieros. Su compensación anual se mantiene sin cambios.
El presidente Dale Wolf expresó su alegría por la continua dirección de Zubretsky, citando la estrategia adecuada, la gran ejecución y la significativa creación de valor para los accionistas bajo su mandato. Este movimiento demuestra el compromiso de Molina de mantener un liderazgo estable y de perseguir metas financieras a largo plazo.
몰리나 헬스케어 (NYSE: MOH)는 사장 겸 CEO 조 주브레츠키와의 계약 수정안을 발표하며 그의 리더십을 최소 2027년 말까지 보장했습니다. 이사회의 결정으로 주브레츠키에게, 그는 2017년 11월에 몰리나에 합류한 인물인데, 특별 한정 주식 부여를 수여하여 2027년 말에 수익이 확정되며 특정 재무 목표를 달성해야 합니다. 그의 연간 보수는 변동이 없습니다.
대니얼 울프 회장은 주브레츠키의 지속적인 리더십에 기쁨을 표하며, 그의 재임 기간 동안 회사의 적절한 전략, 훌륭한 실행, 주주를 위한 중요한 가치 창출을 강조했습니다. 이러한 움직임은 몰리나가 안정적인 리더십을 유지하고 장기 재무 목표를 추구할 것을 다짐하는 것을 보여줍니다.
Molina Healthcare (NYSE: MOH) a annoncé une modification de contrat avec le Président et CEO Joe Zubretsky, garantissant son leadership jusqu'à au moins la fin de 2027. Le Conseil d'Administration a attribué à Zubretsky, qui a rejoint Molina en novembre 2017, une allocation d'actions spéciaux exceptionnelle qui sera acquise à la fin de 2027, sous réserve d'atteindre certains objectifs financiers. Sa rémunération annuelle reste inchangée.
Le Président Dale Wolf a exprimé sa satisfaction quant à la continuité du leadership de Zubretsky, soulignant la bonne stratégie, l'excellente exécution et la création de valeur significative pour les actionnaires sous sa direction. Ce mouvement démontre l'engagement de Molina à maintenir une direction stable et à poursuivre des objectifs financiers à long terme.
Molina Healthcare (NYSE: MOH) hat eine Vertragsänderung mit Präsident und CEO Joe Zubretsky angekündigt, die seine Führung mindestens bis Ende 2027 sichert. Der Vorstand hat Zubretsky, der im November 2017 zu Molina kam, ein einmaliges Sonderaktienangebot gewährt, das am Ende von 2027 fällig wird, vorausgesetzt, bestimmte finanzielle Ziele werden erreicht. Seine jährliche Vergütung bleibt unverändert.
Vorsitzender Dale Wolf äußerte seine Freude über Zubretskys fortwährende Führung und hob die richtige Strategie, großartige Umsetzung und signifikante Wertschöpfung für die Aktionäre während seiner Amtszeit hervor. Dieser Schritt zeigt Molinas Engagement für eine stabile Führung und die Verfolgung langfristiger finanzieller Ziele.
- CEO Joe Zubretsky's tenure secured through 2027, ensuring leadership stability
- Special one-time stock grant tied to financial performance, aligning CEO interests with shareholders
- Board's confidence in current strategy and execution under Zubretsky's leadership
- None.
“Under Joe’s leadership we have the right strategy, great execution, and have created significant value for shareholders,” said Dale Wolf, Molina’s Chairman of the Board. “We are delighted that Joe will be at the helm for the foreseeable future to continue to do so.”
Under this contract amendment, Zubretsky was awarded a special one-time stock grant that will vest at the end of 2027 contingent upon the achievement of certain financial targets. His annual compensation remains unchanged.
About Molina Healthcare
Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. For more information about Molina Healthcare, please visit MolinaHealthcare.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240820987226/en/
Investor Contact: Jeff Geyer, Jeffrey.Geyer@molinahealthcare.com, 305-317-3012
Media Contact: Caroline Zubieta, Caroline.Zubieta@molinahealthcare.com, 562-951-1588
Source: Molina Healthcare, Inc.
FAQ
What is the new employment agreement for Molina Healthcare's CEO Joe Zubretsky?
How long has Joe Zubretsky been the CEO of Molina Healthcare (MOH)?
What is the stock ticker symbol for Molina Healthcare?
How does Molina Healthcare's new CEO agreement affect shareholders?
